Recent AI-based advances, particularly in generative AI, coupled with the challenging macroeconomic environment, have put the spotlight squarely on AI and data-driven offerings, shifting the focus away from other subsectors of digital health. We are seeing increased interest among biopharmaceutical, tech and MedTech companies in AI applications in healthcare, as innovators discover use cases in drug discovery and development, personalized medicine, and other applications.
Read more here: MedTech Update Q2 2023 | Freshfields Bruckhaus Deringer